HYUGA PRIMARY CARE Co.,Ltd.
Q1 Summary for the Fiscal Year Ending March 2027
Sales increased by 27% YoY, led by the home-visit pharmacy business. Expansion of Kirari Prime and Primary Care Home businesses and store openings contributed. The impact of opening new stores and changes in cost items led to fluctuations in operating income. The full-year outlook will be presented in a separate document.
Key Figures
- Sales: Unknown
- Operating income: Unknown
- Contribution from home-visit pharmacy business: Unknown
AI要約
Section header
The financial summary emphasizes the contribution of the home-visit pharmacy business as a growth driver, with expansion of Kirari Prime and Primary Care Home businesses progressing. Increases in store numbers and costs for new openings influence profitability, and key factors shaping this period's earnings trajectory are delineated.
Second section header
Segment-wise, the home-visit pharmacy business contributes significantly, with other businesses also expected to grow. The full-year outlook is provided in a separate document, and efficiency gains from further DX initiatives and facility expansion are anticipated to lift profits.
HYUGA PRIMARY CARE Corporation
Company overview · Stock price · Financial data · All IR
